|
For Release December 10, 2002
The Monitoring the Future Survey, funded by the National Institute on Drug Abuse (NIDA) at the National Institutes of Health (NIH), tracks illicit drug use and attitudes of 8th, 10th, and 12th grade students. It is one of three major surveys through which the U.S. Department of Health and Human Services (HHS) monitors the nation's substance abuse patterns. Information from these surveys helps the nation to identify potential drug problem areas and ensure that resources are targeted to areas of greatest need.
| WHAT: |
The National Institute on Drug Abuse (NIDA) is convening a press conference to announce the results of the 2002 Monitoring the Future Survey of 8th, 10th and 12th graders about drug use.
|
| WHEN: |
Monday, December 16, 2002
9:30 a.m.
|
| WHERE: |
The National Press Club
First Amendment Room
529 - 14th Street, N.W.
Washington, D.C. 20045
|
| WHO: |
Featured speakers:
Glen R. Hanson, Ph.D., D.D.S.
Acting Director, National Institute on Drug Abuse
John P. Walters
Director, Office of National Drug Control Policy
Charles G. Curie
Administrator, Substance Abuse and Mental Health Services Administration
|
Media are invited to attend. For more information or to arrange an interview, call the NIDA Press Office at 301-443-6245.
Note: All HHS press releases, fact sheets and other press materials are available at www.hhs.gov/news
The National Institute on Drug Abuse is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports more than 85 percent of the world's research on the health aspects of drug abuse and addiction. The Institute carries out a large variety of programs to ensure the rapid dissemination of research information and its implementation in policy and practice. Fact sheets on the health effects of drugs of abuse and further information on NIDA research can be found on the NIDA web site at http://www.drugabuse.gov.
|
|
For more information about any item in this Release:
- NIDA Contact:
Blair Gately
Michelle Person
301-443-6245
|
|
